St. Jude Medical (STJ) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts STJ Hot Sheet
Price: $80.82 --0%
Financial Fact:
Earnings before income taxes: 245M
Today's EPS Names:
CCEL, MHGU, PLG, More
Financial Fact:
Earnings before income taxes: 245M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
St. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.55 billion.
Third Quarter and Full-Year 2016 Sales and Earnings Guidance
Due to the planned merger with Abbott, St. Jude Medical is withdrawing financial guidance for the fiscal year 2016.
For earnings history and earnings-related data on St. Jude Medical (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- JPMorgan Starts Shinsegae Inc (004170:KS) at Overweight
- Trex raises 2026 guidance, names SBP as sole national distributor
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
